On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-02-01
DOI
10.3389/fphar.2019.01664
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Drug repurposing for antimicrobial discovery
- (2019) Maya A. Farha et al. Nature Microbiology
- Drug Repurposing for the Treatment of Bacterial and Fungal Infections
- (2019) Andrea Miró-Canturri et al. Frontiers in Microbiology
- Can cardiovascular drugs support cancer treatment? The rationale for drug repurposing
- (2019) Katarzyna Regulska et al. DRUG DISCOVERY TODAY
- The European Medicines Agency’s goals for regulatory science to 2025
- (2019) Philip A. Hines et al. NATURE REVIEWS DRUG DISCOVERY
- Drug Repositioning in Oncology
- (2019) Marissa B. Serafin et al. AMERICAN JOURNAL OF THERAPEUTICS
- Finding hidden treasures in old drugs: the challenges and importance of licensing generics
- (2018) Melek Simsek et al. DRUG DISCOVERY TODAY
- Overcoming the legal and regulatory barriers to drug repurposing
- (2018) Alasdair Breckenridge et al. NATURE REVIEWS DRUG DISCOVERY
- The promise and challenges of drug repurposing in psychiatry
- (2018) Maurizio Fava World Psychiatry
- Dutch hospital makes own drug for rare condition after manufacturer hikes price to €170 000
- (2018) Tony Sheldon BMJ-British Medical Journal
- New uses for old drugs
- (2018) Pan Pantziarka et al. BMJ-British Medical Journal
- Dutch hospital makes own drug for rare condition after manufacturer hikes price to €170 000
- (2018) Tony Sheldon BMJ-British Medical Journal
- New uses for old drugs
- (2018) Pan Pantziarka et al. BMJ-British Medical Journal
- Outdated Prescription Drug Labeling
- (2018) Michael B. Shea et al. Therapeutic Innovation & Regulatory Science
- Repurposing old drugs in oncology: Opportunities with clinical and regulatory challenges ahead
- (2018) Rashmi R. Shah et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- CNS repurposing - Potential new uses for old drugs: Examples of screens for Alzheimer's disease, Parkinson's disease and spasticity
- (2018) Chris G. Parsons NEUROPHARMACOLOGY
- The drug repurposing landscape from 2012 to 2017: evolution, challenges, and possible solutions
- (2018) Prasanthi Polamreddy et al. DRUG DISCOVERY TODAY
- Drug repurposing: progress, challenges and recommendations
- (2018) Sudeep Pushpakom et al. NATURE REVIEWS DRUG DISCOVERY
- Encouraging New Uses for Old Drugs
- (2017) Rachel E. Sachs et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Scientific advice — is drug repurposing missing a trick?
- (2017) Pan Pantziarka Nature Reviews Clinical Oncology
- Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics
- (2017) J. Javier Hernandez et al. Frontiers in Oncology
- Extensions of indication throughout the drug product lifecycle: a quantitative analysis
- (2016) Joris Langedijk et al. DRUG DISCOVERY TODAY
- Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds
- (2016) Roberto Würth et al. DRUG DISCOVERY TODAY
- Reincarnated medicines: using out-dated drugs for novel indications
- (2016) Roberto Ferrari et al. EUROPEAN HEART JOURNAL
- Time to Reassess the Cancer Compendia for Off-label Drug Coverage in Oncology
- (2016) Angela K. Green et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Can you teach old drugs new tricks?
- (2016) Nicola Nosengo NATURE
- Repurposing Drugs to Target the Diabetes Epidemic
- (2016) Nigel Turner et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Association of Off-label Drug Use and Adverse Drug Events in an Adult Population
- (2016) Tewodros Eguale et al. JAMA Internal Medicine
- Drug repositioning and repurposing: terminology and definitions in literature
- (2015) Joris Langedijk et al. DRUG DISCOVERY TODAY
- The Roles Of Academia, Rare Diseases, And Repurposing In The Development Of The Most Transformative Drugs
- (2015) Aaron S. Kesselheim et al. HEALTH AFFAIRS
- Drug repurposing in oncology—patient and health systems opportunities
- (2015) Francesco Bertolini et al. Nature Reviews Clinical Oncology
- A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma
- (2015) Christine Léauté-Labrèze et al. NEW ENGLAND JOURNAL OF MEDICINE
- The problem with repurposing: Is there really an alternative to Big Pharma for developing new drugs for multiple sclerosis?
- (2015) Gavin Giovannoni et al. Multiple Sclerosis and Related Disorders
- Ethical and legal framework and regulation for off-label use: European perspective
- (2014) Christian Lenk et al. Therapeutics and Clinical Risk Management
- Overcoming obstacles to repurposing for neurodegenerative disease
- (2014) Diana W. Shineman et al. Annals of Clinical and Translational Neurology
- Systematic Review: Reliability of Compendia Methods for Off-Label Oncology Indications
- (2013) Amy P. Abernethy ANNALS OF INTERNAL MEDICINE
- Challenges and opportunities of drug repositioning
- (2013) Natalia Novac TRENDS IN PHARMACOLOGICAL SCIENCES
- Repurposing as a strategy for orphan drug development, evidence from European approvals
- (2013) Peter Norman Expert Opinion on Orphan Drugs
- Drug Repurposing: Far Beyond New Targets for Old Drugs
- (2012) T. I. Oprea et al. AAPS Journal
- Repurposing Approved and Abandoned Drugs for the Treatment and Prevention of Cancer through Public-Private Partnership
- (2012) S. J. Weir et al. CANCER RESEARCH
- Drug repurposing in pediatrics and pediatric hematology oncology
- (2012) Julie Blatt et al. DRUG DISCOVERY TODAY
- Hybrid or Mixed Marketing Authorization Application in the European Union
- (2012) Andreas M. Vogel DRUG INFORMATION JOURNAL
- Do we need authorized orphan drugs when compounded medications are available?
- (2012) M. Dooms et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- PHP15 What Price do we Pay for Repurposing Medicines for Rare Diseases?
- (2012) S. Simoens et al. VALUE IN HEALTH
- Off-label use of approved drugs
- (2009) Vincent T. DeVita Nature Reviews Clinical Oncology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started